Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone in Chronic Hypersensitivity Pneumonitis
NCT02496182Phase 3Unknown
- Sponsor
- Grupo Medifarma
- Start
- Jul 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pirfenidone in chronic hypersensitivity pneumonitis (cHP), sponsored by Grupo Medifarma. Status: unknown.
02
Drugs
pirfenidone
03
Conditions
chronic hypersensitivity pneumonitis (cHP)
Beyond the preview
Go deeper on NCT02496182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496182.